Press release
Epileptic Seizures Treatment Market Analysis, Trends, Growth, Research And Forecast 2033
Epileptic Seizures Treatment Market
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=15803&type=smp
According to The Business Research Company's, The epileptic seizures treatment market size has grown strongly in recent years. It will grow from $3.21 billion in 2023 to $3.42 billion in 2024 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to advancements in antiepileptic drugs (AEDs), research breakthroughs in epilepsy treatment, increased awareness and education, expanded access to healthcare, and a rise in the prevalence of epilepsy.
The epileptic seizures treatment market size is expected to see strong growth in the next few years. It will grow to $4.43 billion in 2028 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to precision medicine approaches, emerging therapeutic modalities, telemedicine and remote monitoring, healthcare integration and multidisciplinary care, and regulatory support and incentives. Major trends in the forecast period include personalized medicine, integration of digital health solutions, emerging therapeutic modalities, focus on comorbidities and quality of life, and regulatory support and market access.
Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/epileptic-seizures-treatment-global-market-report
Market Drivers and Trends:
The shift towards personalized medicine in the life sciences industry is expected to propel the growth of data monetization solutions for the life science companies' market going forward. The personalized medicine in the life sciences industry refers to tailoring medical treatments to individual genetic, environmental, and lifestyle factors for more effective and targeted healthcare. The shift towards personalized medicine generates the need to analyze vast patient data, driving demand for advanced data analytics and monetization solutions for life science companies. For instance, in February 2024, according to a report published by the Personalized Medicine Coalition, a US-based organization, in 2023, the FDA approved 16 new personalized treatments for rare disease patients, up from six in 2022. Therefore, the shift towards personalized medicine in the life sciences industry is driving the growth of data monetization solutions for life science companies' markets.
Major companies operating in the epileptic seizures treatment market are developing innovative treatment solutions, such as cannabi*s-based drugs, to provide effective alternatives for patients, particularly those who do not respond to conventional antiseizure medications. Cannabi*s-based drugs are pharmaceutical products derived from the cannabi*s plant, specifically formulated to utilize the therapeutic properties of cannabinoids to treat various medical conditions. These drugs are also primarily used for their anticonvulsant properties, helping to reduce the frequency and severity of seizures in patients with epilepsy. For instance, in January 2024, Akumentis Healthcare Ltd., an India-based pharmaceutical company, launched Clasepi, a Drug Controller General of India (DCGI)-approved prescription cannabi*s plant-based medicine to treat seizures in children, particularly those with Lennox-Gastaut syndrome, Dravet syndrome, or Tuberous Sclerosis Complex. This cannabidio*l oral solution contains less than 0.1% tetrahydrocannabinol (THC) and has demonstrated efficacy in reducing seizures, especially where conventional antiseizure medications have failed. Clasepi aims to address the needs of severe epilepsy cases, though it is not recommended for individuals allergic to cannabidio*l or its ingredients.
Key Benefits for Stakeholders:
• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.
Major Key Players of the Market:
Pfizer Inc., Johnson & Johnson Service Inc., Sanofi S.A., Abbott Laboratories, Novartis AG, GlaxoSmithKline plc., Takeda Pharmaceutical Co. Ltd., Medtronic plc, GE HealthCare Technologies Inc., Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., UCB S.A., Eisai Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd., Dragerwerk AG & Co.KGaA, H. Lundbeck A/S, Apotex Inc., Masimo Corporation, Fisher & Paykel Healthcare Limited, Inspiration Healthcare Group Plc., Phoenix Medical Systems (P) Ltd., Marinus Pharmaceuticals Inc., Alexza Pharmaceuticals Inc., Neurelis Inc., Veriton Pharma
Epileptic Seizures Treatment Market 2024 Key Insights:
• The epileptic seizures treatment market size is expected to see strong growth in the next few years. It will grow to $4.43 billion in 2028 at a compound annual growth rate (CAGR) of 6.7%.
• Increasing Prevalence Of Epilepsy Driving Growth In The Epileptic Seizures Treatment Market
• Development Of Cannabi*s-Based Drugs For Epileptic Seizures Treatment
• North America was the largest region in the epileptic seizures treatment market in 2023
We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/Customise?id=15803&type=smp
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Epileptic Seizures Treatment Market Analysis, Trends, Growth, Research And Forecast 2033 here
News-ID: 3704712 • Views: …
More Releases from The Business research company
Competitive Analysis: Leading Companies and New Entrants in the Wire Arc Additiv …
The wire arc additive manufacturing cell market is rapidly gaining traction as industries increasingly embrace advanced metal 3D printing technologies. With significant investments and technological breakthroughs, this sector is set to experience remarkable growth, transforming manufacturing processes across multiple fields. Let's explore the market's size, influential players, key trends, and segmentation to understand its future trajectory.
Projected Expansion of the Wire Arc Additive Manufacturing Cell Market
The wire arc additive manufacturing cell…
Future Perspectives: Key Trends Shaping the Viscosupplementation Treatment for A …
The viscosupplementation treatment for arthritis market is on the verge of significant expansion, driven by advances in medical technology and a growing demand for effective arthritis therapies. With increasing awareness around early intervention and new treatment options, this sector is poised for rapid development over the coming years. Let's explore the market size, key players, emerging trends, and segment-wise forecasts that define this growing industry.
Projected Market Growth and Size of…
Segmentation, Major Trends, and Competitive Overview of the Viral Vector Develop …
The viral vector development service market is set to experience substantial growth in the coming years, driven by technological progress and increasing demand from various sectors. As gene therapies and advanced treatments gain prominence, the need for efficient viral vector production and development is becoming more critical. Let's explore the market size projections, key players, emerging trends, and the segment structure shaping this industry's future.
Projected Expansion and Market Size of…
Competitive Landscape: Leading Companies and New Entrants in the Transient Elast …
The transient elastography market is poised for substantial expansion as advancements in healthcare diagnostics continue to evolve. Increasing emphasis on non-invasive techniques and early disease detection is driving widespread adoption, setting the stage for strong market growth in the coming years. Let's explore the current market valuation, leading players, emerging innovations, and key segments shaping this industry.
Projected Market Value and Growth of the Transient Elastography Market
The transient elastography market is…
More Releases for Epileptic
Developmental and Epileptic Encephalopathies (DEE) - Patient Pool Analysis & Mar …
What are DEEs?
Developmental and epileptic encephalopathies (DEEs) are a group of rare, severe, early-onset epilepsies in which epileptic activity itself contributes to progressive cognitive, motor and behavioural impairment. They include syndromes such as infantile epileptic spasms (West syndrome), Lennox-Gastaut syndrome (LGS), Dravet syndrome (DS), epilepsy with myoclonic-atonic seizures (EMAS/Doose), CDKL5 deficiency and many single-gene epilepsies.
Children often present in the first months or years of life with multiple seizure types, resistant…
Prominent Epileptic Seizures Treatment Market Trend for 2025: Development -Based …
What combination of drivers is leading to accelerated growth in the epileptic seizures treatment market?
The growing prevalence of epilepsy is anticipated to drive the growth of the epileptic seizures treatment market. Epilepsy is characterized by recurrent seizures caused by abnormal brain activity, leading to symptoms like convulsions or loss of consciousness. The rise in epilepsy cases is attributed to factors such as increased survival rates for brain injuries and strokes,…
Poland Epileptic Seizures Treatment Market Foreseen to Grow Exponentially 2030
Epileptic Seizures Treatment Market: Introduction
According to the report, the global epileptic seizures treatment market was valued at US$ 1.2 Bn in 2019 and is projected to expand at a CAGR of ~4% from 2020 to 2030. In epilepsy, the brain activity becomes abnormal, resulting in recurrent seizures that are short episodes of involuntary movement, which may involve a part of the body or the entire body. These seizures in some cases cause loss of…
Epileptic Seizures Treatment Market: Lucrative Opportunities
Epileptic Seizures Treatment Market: Introduction
According to the report, the global epileptic seizures treatment market was valued at US$ 1.2 Bn in 2019 and is projected to expand at a CAGR of ~4% from 2020 to 2030. In epilepsy, the brain activity becomes abnormal, resulting in recurrent seizures that are short episodes of involuntary movement, which may involve a part of the body or the entire body. These seizures in some cases cause loss of…
Epileptic Seizure Monitoring System Market Projected to Register CAGR to 2027
The epileptic seizure monitor system is a seizure detection system that can be used in long-term and home situations for early intervention and prevention of seizure-related side effects, including SUDEP.
The epileptic seizure monitoring system market is segmented by company, region (country), type, and application. Players, stakeholders, and other entrants of the global Seizure Monitoring System market can use the report as a powerful resource to gain an edge.
(Get 15% Discount…
Epileptic Seizures Treatment Market: Technological advancements in the field of …
Epileptic Seizures Treatment Market: Introduction
According to the report, the global epileptic seizures treatment market was valued at US$ 1.2 Bn in 2019 and is projected to expand at a CAGR of ~4% from 2020 to 2030. In epilepsy, the brain activity becomes abnormal, resulting in recurrent seizures that are short episodes of involuntary movement, which may involve a part of the body or the entire body. These seizures in some…
